Florica Popescu

Prof. Dr. Florica Popescu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2024 in Life
Verified
Journal Article
Open access
PDF file
CACătălina Mihaela Anastasescu
Cătălina Mihaela Anastasescu
VGVeronica Gheorman
Veronica Gheorman
ESEugen-Cristi Stoicanescu
Eugen-Cristi Stoicanescu
FPFlorica Popescu
Florica Popescu
GVGheorman Victor
Gheorman Victor
IUIon Udriștoiu
Ion Udriștoiu
Background: Autism spectrum disorder (ASD) has seen a rise in prevalence, and the immune system’s role in brain development is increasingly recognized. This study investigates the relationship between immune dysregulation and ASD by examining serum concentrations of interleukin 6 (IL-6), interleukin 8 (CXCL8), and tumor necrosis factor alpha (TNF-alpha) in children. Methods: Serum samples from 45 children with ASD and 30 controls, aged 2 to 12 years, were analyzed using electrochemiluminescence, chemiluminescent microparticle immunoassay, and chemiluminescent immunoassay. ASD symptoms were assessed using the Autism Spectrum Rating Scale (ASRS) and Social Communication Questionnaire (SCQ). Results: No significant correlation was observed between CXCL8 levels and ASD. IL-6 levels showed a trend toward elevation in boys with ASD. TNF-alpha levels were significantly higher in children with ASD under 5 years compared to older children and controls, though no correlation with symptom severity was found. Conclusions: TNF-alpha may be a potential biomarker for early ASD detection, especially in younger children. Further research on larger cohorts is needed to understand the role of immune dysregulation in ASD.

15 May 2024 in Life
Verified
Journal Article
Open access
PDF file
CACătălina Mihaela Anastasescu
Cătălina Mihaela Anastasescu
VGVeronica Gheorman
Veronica Gheorman
FPFlorica Popescu
Florica Popescu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
ESEugen Cristi Stoicănescu
Eugen Cristi Stoicănescu
IUIon Udriștoiu
Ion Udriștoiu
Amino acids are organic compounds that enter the protein structure, being involved in the proper functioning of the body. The role of amino acids in the onset of autism spectrum disorder (ASD) is yet to be established. Our aim was to identify correlations between urine amino acids and their derivatives and ASD. Methods: We designed a case–control study that consisted of 75 boys and girls, aged between 2 and 12 years. For amino acid profile, we used urine samples that were analyzed using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Results: Descriptive analysis showed higher values for glutamine, hydroxyproline, tyrosine, aspartic acid, and tryptophan and lower values for serine in the autism group than in the control group. Also, we found that boys with autism had higher values than the boys in the control group for serine, threonine, and aspartic acid. For girls from both groups, we did not find statistically significant values. In terms of age groups, we found significantly higher values for histidine, threonine, valine, methionine, aspartic acid, glutamic acid, alpha amino-adipic acid, sarcosine, alanine, and beta-alanine and significantly lower values for proline for both the autism and control groups under 5 years. Conclusions: The findings of this study support the assumption that amino acids may have a role in the expression of ASD.

17 June 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
NVNicoleta Mirela Voicu
Nicoleta Mirela Voicu
FPFlorica Popescu
Florica Popescu
DFDan Nicolae Florescu
Dan Nicolae Florescu
IRIon Rogoveanu
Ion Rogoveanu
Adina Turcu-StiolicaAdina Turcu-Stiolica
Adina Turcu-Stiolica
Bogdan Silviu UngureanuBogdan Silviu Ungureanu
Bogdan Silviu Ungureanu
Clostridioides difficile infection (CDI) stands as the leading cause of nosocomial infection with high morbidity and mortality rates, causing a major burden on the healthcare system. Driven by antibiotics, it usually affects older patients with chronic disease or immunosuppressed or oncologic management. Variceal bleeding secondary to cirrhosis requires antibiotics to prevent bacterial translocation, and thus patients become susceptible to CDI. We aimed to investigate the risk factors for CDI in cirrhotic patients with variceal bleeding following ceftriaxone and the mortality risk in this patient’s population. We retrospectively screened 367 cirrhotic patients with variceal bleeding, from which 25 patients were confirmed with CDI, from 1 January 2017 to 31 December 2019. We found MELD to be the only multivariate predictor for mortality (odds ratio, OR = 1.281, 95% confidence interval, CI: 0.098–1.643, p = 0.042). A model of four predictors (age, days of admission, Charlson index, Child–Pugh score) was generated (area under the receiver operating characteristics curve, AUC = 0.840, 95% CI: 0.758–0.921, p < 0.0001) to assess the risk of CDI exposure. Determining the probability of getting CDI for cirrhotic patients with variceal bleeding could be a tool for doctors in taking decisions, which could be integrated in sustainable public health programs.

30 June 2021 in Journal of Science and Arts
Verified
Journal Article
Open access
MAManuel Amzoiu
Manuel Amzoiu
FCFlorentina Cristovici
Florentina Cristovici
DADenisa Amzoiu
Denisa Amzoiu
FPFlorica Popescu
Florica Popescu
ANAlexandra Nitulescu
Alexandra Nitulescu
ECEmin Cadar
Emin Cadar
Oxicam derivatives play an important role in the treatment of pain and inflammation. The mechanism of action of these compounds consists in the inhibition of cyclooxygenase (COX) and the blockade of isoform 1 of this enzyme (COX-1) is considered to generate adverse effects. The aim of this paper is to establish which of the atoms in the oxicams molecules are responsible for their inhibitory activities, using electronegativity as fingerprint descriptor. Using this descriptor and molecular docking programs, the atoms in the molecule that have a greater contribution to COX-1 inhibition have been identified. In the case of the studied molecules, the oxygen atoms and the nitrogen atoms are highlighted. The oxygen atoms participate in the interaction as electron acceptors through U-MO molecular levels (74.1%) and the nitrogen atoms participate in the interaction both as a nucleophilic center through the molecular state of HOMO (13.7%) and as an electrophilic center through the molecular state of LUMO (13.2%). In the case of three out of four of the studied compounds, the 4-hydroxyl group of the thiazine ring participates in the interaction with COX-1. The results are also supported by the 2D and 3Ddiagrams of the applied docking method.

18 November 2022 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
RKRoxana Kostici
Roxana Kostici
CPCătălina Gabriela Pisoschi
Cătălina Gabriela Pisoschi
GMGeorge Dan Mogoşanu
George Dan Mogoşanu
ABAndrei Biță
Andrei Biță
APAndreea Silvia Pîrvu
Andreea Silvia Pîrvu
FPFlorica Popescu
Florica Popescu

7 September 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
CACătălina Mihaela Anastasescu
Cătălina Mihaela Anastasescu
VGVeronica Gheorman
Veronica Gheorman
FPFlorica Popescu
Florica Popescu
ESEugen-Cristi Stoicănescu
Eugen-Cristi Stoicănescu
GVGheorman Victor
Gheorman Victor
IUIon Udriștoiu
Ion Udriștoiu
The objective of this study was to analyze the serum amino acid profile in children diagnosed with autistic spectrum disorder (ASD) in southern Romania. The analysis aimed to provide insights into the underlying metabolic dysregulations associated with ASD. ASD is a neurodevelopmental disorder characterized by impaired social interaction, communication deficits, and restricted repetitive behaviors. Although the exact cause of ASD is largely unknown, recent evidence suggests that abnormalities in amino acid metabolism may contribute to its pathogenesis. Therefore, studying the amino acid profile in children with ASD could offer valuable information for understanding the metabolic disturbances associated with this complex disorder. This single-center study examined serum samples from children diagnosed with ASD, utilizing advanced analytical techniques to quantify the levels of different amino acids, amino acid derivatives, and amino acid-like substances. The results showed a lower level of taurine and a higher level of asparagine and leucine in the ASD group versus the control group. In the ASD group, we observed significant differences in tryptophan and alpha-aminobutyric acid levels based on age, with higher tryptophan levels in children older than 7 years when compared to children younger than 7 years; however, no significant correlations were found with the ASD group older than 7 years old. Additionally, younger children with ASD exhibited higher levels of alpha-aminobutyric acid than older children with ASD. The findings from this study contribute to the growing body of knowledge on the metabolic aspects of ASD, highlighting potential biomarkers and therapeutic targets for improving the management and treatment of ASD in children.